Ludger Johannes

Dr. Ludger Johannes

Cellular and Chemical Biology Unit, Institut Curie, PSL Research University, U1143 INSERM, UMR3666 CNRS, 26 rue d’Ulm, 75248 Paris CEDEX 05, France
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2011 in Cell
Verified
Journal Article
Closed access
BSBidisha Sinha
Bidisha Sinha
DKDarius Köster
Darius Köster
RRRichard Ruez
Richard Ruez
PGPauline Gonnord
Pauline Gonnord
MBMichele Bastiani
Michele Bastiani
PNPierre Nassoy
Pierre Nassoy

1 October 2016 in Immunity
Verified
Journal Article
Closed access
RDRomain Daillère
Romain Daillère
MVMarie Vétizou
Marie Vétizou
NWNadine Waldschmitt
Nadine Waldschmitt
TYTakahiro Yamazaki
Takahiro Yamazaki
CIChristophe Isnard
Christophe Isnard
LZLaurence Zitvogel
Laurence Zitvogel

14 February 2005 in Genome Research
Verified
Journal Article
Open access
PDF file
EFEtienne Formstecher
Etienne Formstecher
SASandra Aresta
Sandra Aresta
VCVincent Collura
Vincent Collura
AHAlexandre Hamburger
Alexandre Hamburger
AMAlain Meil
Alain Meil
LDLaurent Daviet
Laurent Daviet
TheDrosophila(fruit fly) model system has been instrumental in our current understanding of human biology, development, and diseases. Here, we used a high-throughput yeast two-hybrid (Y2H)-based technology to screen 102 bait proteins fromDrosophila melanogaster, most of them orthologous to human cancer-related and/or signaling proteins, against high-complexity fly cDNA libraries. More than 2300 protein-protein interactions (PPI) were identified, of which 710 are of high confidence. The computation of a reliability score for each protein-protein interaction and the systematic identification of the interacting domain combined with a prediction of structural/functional motifs allow the elaboration of known complexes and the identification of new ones. The full data set can be visualized using a graphical Web interface, the PIMRider (http://pim.hybrigenics.com), and is also accessible in the PSI standard Molecular Interaction data format. Our fly Protein Interaction Map (PIM) is surprisingly different from the one recently proposed by Giot et al. with little overlap between the two data sets. Analysis of the differences in data sets and methods suggests alternative strategies to enhance the accuracy and comprehensiveness of the post-genomic generation of broad-scale protein interaction maps.

1 May 2018 in Journal of Cell Science
Verified
Journal Article
Closed access
PDF file
Ludger JohannesLudger Johannes
Ludger Johannes
RJRalf Jacob
Ralf Jacob
HLHakon Leffler
Hakon Leffler
Galectins are carbohydrate-binding proteins that are involved in many physiological functions, such as inflammation, immune responses, cell migration, autophagy and signalling. They are also linked to diseases such as fibrosis, cancer and heart disease. How such a small family of only 15 members can have such widespread effects remains a conundrum. In this Cell Science at a Glance article, we summarise recent literature on the many cellular activities that have been ascribed to galectins. As shown on the accompanying poster, these include carbohydrate-independent interactions with cytosolic or nuclear targets and carbohydrate-dependent interactions with extracellular glycoconjugates. We discuss how these intra- and extracellular activities might be linked and point out the importance of unravelling molecular mechanisms of galectin function to gain a true understanding of their contributions to the physiology of the cell. We close with a short outlook on the organismal functions of galectins and a perspective on the major challenges in the field.

1 January 2013 in Cancer Research
Verified
Journal Article
Closed access
CBCécile Badoual
Cécile Badoual
SHStéphane Hans
Stéphane Hans
NMNathalie Merillon
Nathalie Merillon
CRCordélia Van Ryswick
Cordélia Van Ryswick
PRPatrice Ravel
Patrice Ravel
Eric TartourEric Tartour
Eric Tartour
Head and neck cancers positive for human papillomavirus (HPV) have a more favorable clinical outcome than HPV-negative cancers, but it is unknown why this is the case. We hypothesized that prognosis was affected by intrinsic features of HPV-infected tumor cells or differences in host immune response. In this study, we focused on a comparison of regulatory Foxp3+ T cells and programmed death-1 (PD-1)+ T cells in the microenvironment of tumors that were positive or negative for HPV, in two groups that were matched for various clinical and biologic parameters. HPV-positive head and neck cancers were more heavily infiltrated by regulatory T cells and PD-1+ T cells and the levels of PD-1+ cells were positively correlated with a favorable clinical outcome. In explaining this paradoxical result, we showed that these PD-1+ T cells expressed activation markers and were functional after blockade of the PD-1–PD-L1 axis in vitro. Approximately 50% of PD-1+ tumor-infiltrating T cells lacked Tim-3 expression and may indeed represent activated T cells. In mice, administration of a cancer vaccine increased PD-1 on T cells with concomitant tumor regression. In this setting, PD-1 blockade synergized with vaccine in eliciting antitumor efficacy. Our findings prompt a need to revisit the significance of PD-1–infiltrating T cells in cancer, where we suggest that PD-1 detection may reflect a previous immune response against tumors that might be reactivated by PD-1/PD-L1 blockade. Cancer Res; 73(1); 128–38. ©2012 AACR.

29 November 2007 in Nature
Verified
Journal Article
Closed access
WRWinfried Römer
Winfried Römer
LBLudwig Berland
Ludwig Berland
VCValérie Chambon
Valérie Chambon
KGKatharina Gaus
Katharina Gaus
BWBarbara Windschiegl
Barbara Windschiegl
Ludger JohannesLudger Johannes
Ludger Johannes